Hypnotic Effects of Hypericum perforatum L. and Melissa officinalis L. Through Adenosine and Melatonin Receptors
Open Access
Abstract
Background: Sleep disorders, particularly insomnia, represent a major public health concern, while currently available hypnotic drugs are often limited by adverse effects and poor long-term tolerability. Methods: In this study, we investigated the sleep-promoting effects of a mixture of Hypericum perforatum L. and Melissa officinalis L. extract (HME) and its underlying mechanisms in male ICR and C57BL/6 mice. In a pentobarbital-induced sleep model in mice, sleep onset latency and total sleep time were measured. Pharmacological studies using various antagonists and agonists were conducted to elucidate receptor-mediated mechanisms. Immunohistochemical and immunofluorescence analyses were performed to assess neuronal activity, and cortical mRNA expression was evaluated by quantitative analysis. HPLC analysis was used to identify the major constituents of HME, and their pharmacological profiles were functionally evaluated. Results: HME significantly reduced sleep onset latency and prolonged total sleep time. These hypnotic effects were shown to be mediated through adenosine and melatonin receptor signaling pathways. Immunohistochemical and immunofluorescence analyses showed that HME suppressed neuronal activity in wake-promoting cholinergic and orexinergic neurons of the basal forebrain and lateral hypothalamus, while enhancing activation of sleep-promoting GABAergic neurons in the ventrolateral preoptic nucleus. At the molecular level, HME increased cortical mRNA expression levels of adenosine A1 receptor, adenosine A2A receptor, melatonin receptor 1, and melatonin receptor 2. From the HPLC analysis, rosmarinic acid and hyperoside were identified as the major constituents of HME. Functional evaluation of these compounds revealed complementary pharmacological profiles, with hyperoside primarily acting through adenosine receptors and rosmarinic acid engaging both adenosine and melatonin receptor pathways. Conclusions: These findings suggest that HME enhances both sleep initiation and maintenance through adenosine and melatonin receptor signaling pathways, thereby supporting its potential as a multitarget therapeutic agent for improving sleep quality.Keywords
Funding Information
- GRRC program of Gyeonggi province (GRRC-Ajou2023-B01)
- National Research Foundation of Korea (RS-2025-02314060)
This publication has 77 references indexed in Scilit:
- Hyperoside: A review on its sources, biological activities, and molecular mechanismsPhytotherapy Research, 2022
- Involvement of the adenosine A1 receptor in the hypnotic effect of rosmarinic acidBiomedicine & Pharmacotherapy, 2022
- The effects of lemon balm (Melissa officinalis L.) on depression and anxiety in clinical trials: A systematic review and meta‐analysisPhytotherapy Research, 2021
- The mechanisms of action of St. John’s wort: an updateWiener Medizinische Wochenschrift, 2015
- Hypericum perforatum : Pharmacokinetic, Mechanism of Action, Tolerability, and Clinical Drug-Drug InteractionsPhytotherapy Research, 2013
- Insomnia PharmacotherapyNeurotherapeutics, 2012
- In vivo sedative and gastroprotective activities of Salvia plebeia extract and its composition of polyphenolsArchives of Pharmacal Research, 2012
- Effects of Melissa officinalis L. (Lemon Balm) Extract on Neurogenesis Associated with Serum Corticosterone and GABA in the Mouse Dentate GyrusNeurochemical Research, 2010
- Bioassay‐guided fractionation of lemon balm (Melissa officinalisL.) using anin vitromeasure of GABA transaminase activityPhytotherapy Research, 2009
- Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studiesPsychopharmacology, 1997